人类多能干细胞中TP53的枯竭会触发恶性行为
Joaquin Montilla-Rojo1, Thomas F Eleveld2, Marnix van Soest1
1Anatomy and Physiology, Department Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, 3584 CL, The Netherlands.
Advanced biology
|January 6, 2025
概括
人类多能干细胞 (hPSC) 中的TP53突变可能导致遗传变化和对化疗的抗性增加. 这些变化可能会影响hPSCs临床使用的安全性.
科学领域:
- 干细胞生物学 干细胞生物学
- 癌症遗传学 癌症遗传学
- 基因编辑CRISPR基因编辑
背景情况:
- 人类多能干细胞 (hPSCs) 可以在体外培养过程中积累遗传突变.
- 在hPSC中,TP53瘤抑制基因突变很常见,可能提供增长优势.
研究的目的:
- 调查TP53淘汰对hPSC行为和安全的影响.
- 为了比较TP53缺乏的hPSCs与野生类型细胞和生殖细胞瘤系.
主要方法:
- 通过CRISPR-Cas9基因编辑,在hPSC中消除TP53.
- 同源性野生型和TP53敲门式hPSC的比较.
- 对增殖,多能性,转录组学,染色体异常和耐药性的分析.
主要成果:
- 淘汰TP53并没有显著改变扩散,多能性或全球转录组特征.
- 突变hPSCs在常见的热点显示染色体异常.
- 在缺乏TP53的hPSC中观察到增强的克隆基因和无结的生长.
- 在突变系中注意到对化疗剂的耐药性增加.
结论:
- 在hPSCs中的TP53突变,即使是微妙的,也会影响它们的行为和安全性.
- 这些发现凸显了TP53改变的hPSC临床应用的潜在风险.
- 标准分析可能会忽略hPSCs中TP53突变的影响.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K


